Bilgilendirme: Kurulum ve veri kapsamındaki çalışmalar devam etmektedir. Göstereceğiniz anlayış için teşekkür ederiz.

Publication:
The Protective Effect of Astaxanthin on Cisplatin-Induced Ototoxicity

dc.authorwosidYilmaz, Adnan/Abb-9340-2020
dc.authorwosidDursun, Engin/Hgc-1700-2022
dc.authorwosidDursun, Engin/Hgc-1700-2022
dc.authorwosidYılmaz, Adnan/Abb-9340-2020
dc.authorwosidDemir, Emine/A-5953-2019
dc.authorwosidMercantepe, Tolga/O-1073-2013
dc.contributor.authorTerzi, Suat
dc.contributor.authorOzgur, Abdulkadir
dc.contributor.authorCeliker, Metin
dc.contributor.authorMercantepe, Tolga
dc.contributor.authorYilmaz, Adnan
dc.contributor.authorTumkaya, Levent
dc.contributor.authorDursun, Engin
dc.contributor.authorIDTumkaya, Levent/0000-0002-2814-5194
dc.contributor.authorIDKaya, Şeyma/0000-0002-1150-6467
dc.contributor.authorIDDursun, Engin/0000-0002-2070-8677
dc.contributor.authorIDDursun, Engin/0000-0002-2070-8677
dc.contributor.authorIDYılmaz, Adnan/0000-0003-4842-1173
dc.contributor.authorIDÖzgür, Abdulkadir/0000-0002-6155-5988
dc.date.accessioned2025-12-11T01:38:48Z
dc.date.issued2021
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Terzi, Suat; Celiker, Metin; Kaya, Seyma; Demir, Emine; Dursun, Engin] Recep Tayyip Erdogan Univ, Fac Med, Dept Otorhinolaryngol, Rize, Turkey; [Ozgur, Abdulkadir] Ondokuz Mayis Univ, Samsun Hlth Practices & Res Ctr, Dept Otorhinolaryngol, Samsun, Turkey; [Mercantepe, Tolga; Tumkaya, Levent] Recep Tayyip Erdogan Univ, Fac Med, Dept Histol & Embryol, Rize, Turkey; [Yilmaz, Adnan] Recep Tayyip Erdogan Univ, Fac Med, Dept Biochem, Rize, Turkeyen_US
dc.descriptionTumkaya, Levent/0000-0002-2814-5194; Kaya, Şeyma/0000-0002-1150-6467; Dursun, Engin/0000-0002-2070-8677; Dursun, Engin/0000-0002-2070-8677; Yılmaz, Adnan/0000-0003-4842-1173; Özgür, Abdulkadir/0000-0002-6155-5988; Mercantepe, Tolga/0000-0002-8506-1755;en_US
dc.description.abstractBackground. Promising studies have been conducted with many substances to reduce the ototoxic effects of cisplatin, but there is no treatment that completely eliminates the ototoxic effect. Objectives. To determine the effectiveness of astaxanthin (ASX) as a protective agent against cisplatin-induced ototoxicity. Materials and methods. Thirty-six rats were randomly divided into 6 groups. Group 1 received no drug injections except for anesthetics; group 2 received intraperitoneal (IP) olive oil only for 8 days; group 3 received only IP ASX 75 mg/kg dissolved in olive oil for 8 days; group 4 received a single dose of only IP 16 mg/kg cisplatin on the 5th day; group 5 received 25 mg/kg ASX IP daily for 8 days and a single 16 mg/kg dose of cisplatin on the 5th day; group 6 received 75 mg/kg ASX IP daily for 8 days and a single 16 mg/kg dose of cisplatin on the 5th day. The animals were tested for distortion product otoacoustic emissions (DPOAE) before and 3 days after cisplatin treatment. The animals in all groups were sacrificed under anesthesia on the 10th day. Before sacrifice, inferior vena cava blood samples were drawn into commercial tubes for biochemical analysis and their cochlea were prepared for histological analysis. Results. The ASX+cisplatin groups demonstrated significantly higher DPOAE thresholds when compared to the cisplatin-only group (p < 0.05). The ASX 25 mg/kg/day+cisplatin group showed a significant increase in total antioxidant capacity compared to the cisplatin-only group, whereas the ASX 75 mg/kg/day+cisplatin group had significantly lower total oxidative stress and oxidative stress index. Histologic results showed that the cortical organ was better preserved in the ASX+cisplatin groups compared to the cisplatin-only group, and the degeneration in the spiral ganglion and inner and outer hair cells was less visible in the ASX groups. Conclusions. Astaxanthin can protect hearing from cisplatin-induced ototoxicity, prevent cellular degeneration and significantly reduce oxidative stress.en_US
dc.description.sponsorshipRecep Tayyip Erdogan University Scientific Research Project Unit (RTEUBAP) [2016/360]en_US
dc.description.sponsorshipThis work was supported by Recep Tayyip Erdogan University Scientific Research Project Unit (RTEUBAP) under the project number of 2016/360. Compliance with ethical standards; the study was performed in accordance with the 2011 Guide for the Care and Use of Laboratory Animalsen_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.doi10.17219/acem/133081
dc.identifier.endpage321en_US
dc.identifier.issn1899-5276
dc.identifier.issn2451-2680
dc.identifier.issue3en_US
dc.identifier.pmid33789004.0
dc.identifier.scopusqualityQ3
dc.identifier.startpage315en_US
dc.identifier.urihttps://doi.org/10.17219/acem/133081
dc.identifier.urihttps://hdl.handle.net/20.500.12712/45130
dc.identifier.volume30en_US
dc.identifier.wosWOS:000636231700011
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherWroclaw Medical Univen_US
dc.relation.ispartofAdvances in Clinical and Experimental Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCisplatinen_US
dc.subjectAstaxanthinen_US
dc.subjectOtotoxicityen_US
dc.titleThe Protective Effect of Astaxanthin on Cisplatin-Induced Ototoxicityen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files